Andrew Galler
Stock Analyst at Morgan Stanley
(0.59)
# 4,110
Out of 5,174 analysts
30
Total ratings
33.33%
Success rate
-15.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Maintains: Equal-Weight | $34 → $36 | $29.95 | +20.22% | 14 | Nov 10, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $14.41 | +4.09% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $5.20 | +246.15% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $56.27 | -34.25% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $69.68 | -19.63% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $8.57 | +110.04% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $64.54 | -16.33% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $62.04 | -19.41% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $3.94 | +1,016.75% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $51.34 | +492.13% | 1 | Nov 9, 2021 |
Immunocore Holdings
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $34 → $36
Current: $29.95
Upside: +20.22%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $14.41
Upside: +4.09%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $5.20
Upside: +246.15%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $56.27
Upside: -34.25%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $69.68
Upside: -19.63%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $8.57
Upside: +110.04%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $64.54
Upside: -16.33%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $62.04
Upside: -19.41%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $3.94
Upside: +1,016.75%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $51.34
Upside: +492.13%